• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by WW International Inc.

    4/3/26 2:11:35 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary
    Get the next $WW alert in real time by email
    8-K
    false 0000105319 --12-31 0000105319 2026-03-30 2026-03-30
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of report (Date of earliest event reported): March 30, 2026

     

     

    WW INTERNATIONAL, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Virginia   001-16769   11-6040273

    (State or other jurisdiction

    of incorporation)

     

    (Commission File

    Number)

     

    (IRS Employer

    Identification No.)

     

    18 West 18th Street, 7th Floor, New York, New York   10011
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (212) 589-2700

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, no par value   WW   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Departure of President and Chief Executive Officer

    On March 30, 2026, Tara Comonte notified the board of directors (the “Board”) of WW International, Inc. (the “Company”) of her resignation as the President and Chief Executive Officer of the Company, effective March 31, 2026. On March 31, 2026, the Board accepted Ms. Comonte’s resignation. Pursuant to her employment agreement with the Company, upon Ms. Comonte’s termination of employment with the Company, she was deemed to have resigned as a member of the Board and from any and all other directorships, committee memberships, and all other positions that she held with the Company and its subsidiaries.

    Effective April 3, 2026, the Company has established an Interim Office of the Chief Executive Officer (“OCEO”), comprised of Felicia DellaFortuna, the Company’s Chief Financial Officer, and Jonathan Volkmann, the Company’s Chief Operations Officer, to serve as the principal executive officers of the Company on an interim basis until such time as the Board appoints Ms. Comonte’s successor. Biographical information for each of Ms. DellaFortuna and Mr. Volkmann is set forth below.

    Felicia DellaFortuna, 42, has served as Chief Financial Officer of the Company since January 2025. Prior to joining the Company, she was Chief Financial Officer of Enthusiast Gaming Holdings Inc., a gaming media and entertainment company, from November 2023 to December 2024. Prior to that, she served as Chief Financial Officer of BuzzFeed, Inc., a digital media company, from December 2021 to November 2023. Ms. DellaFortuna previously served in several finance leadership positions at BuzzFeed’s predecessor company, including as its Chief Financial Officer from February 2020 to December 2021, Senior Vice President of Finance from May 2019 to February 2020, Vice President of Finance from June 2017 to May 2019, and Senior Director of Finance from October 2015 to June 2017. Prior to that time, Ms. DellaFortuna held corporate finance positions with Viant Technology Inc. and XIX Entertainment Limited, and provided assurance services at Ernst & Young LLP. She holds a Certified Public Accountant license in New York. Ms. DellaFortuna received a B.S. in Accounting from Lehigh University.

    Jonathan Volkmann, 39, has served as Chief Operations Officer of the Company since June 2025, having previously served as Senior Vice President, Global Operations since January 2025. Mr. Volkmann was the Chief Operating Officer at Weekend Health, Inc. (d/b/a Sequence, now WW Clinic) from March 2022 to January 2025. From April 2019 to March 2022, he held several leadership positions at Eaze Inc., including Vice President, Marketplace and Vice President, Central Operations. Earlier in his career, he served in various operational roles at Uber and DogVacay (acquired by Rover). Mr. Volkmann holds a B.S. in Business Administration from the University of Richmond and an M.B.A. from the UCLA Anderson School of Management.

    Neither Ms. DellaFortuna nor Mr. Volkmann have any family relationships with any director or executive officer of the Company. Additionally, neither Ms. DellaFortuna nor Mr. Volkmann have engaged in any transaction that would be reportable as a related party transaction under Item 404(a) of Regulation S-K.

    Departure of Chief Legal and Administrative Officer and Secretary

    On March 31, 2026, Jaqueline Cooke notified the Board of her resignation as Chief Legal and Administrative Officer and Secretary of the Company, at the request of the Board and not due to circumstances constituting “cause”, effective April 10, 2026 (the “Separation Date”).

    In connection with her termination of employment, on March 31, 2026, Ms. Cooke and the Company entered into a Separation Agreement and Mutual Release (the “Separation Agreement”), the material terms of which are described below. As consideration for a customary broad-form mutual release of claims by Ms. Cooke against the Company and its affiliates, and by the Company against Ms. Cooke and her affiliates, the Company will provide Ms. Cooke the following payments and benefits: (i) a separation payment in an aggregate amount of $1,500,000 to be paid in cash in two equal installments, the first of which will be paid on the first regularly scheduled payroll date occurring 45 days after the Separation Date and the second of which will be paid on the first regularly scheduled payroll date in July 2026; and (ii) payment of the employer’s portion of the premium for maintenance of health insurance under the Consolidated Omnibus Budget Reconciliation Act and the California Continuation Benefits Replacement Act for up to 36 months following the Separation Date (or, if earlier, the date that Ms. Cooke is eligible for group health insurance coverage through another employer). In accordance with the Company’s 2025 Stock Incentive Plan (the “Stock Incentive Plan”) and applicable award agreements thereunder, Ms. Cooke’s equity- and cash-based awards under the Stock Incentive Plan will immediately be forfeited as of the Separation Date. The Company will reimburse Ms. Cooke for attorneys’ fees and costs incurred in connection with Ms. Cooke’s separation from the Company and negotiation of the Separation Agreement, in an amount equal to $107,480. The Separation Agreement further includes a customary cooperation covenant on behalf of Ms. Cooke for the benefit of the Company and a mutual non-disparagement covenant.

     

    2


    The foregoing summary and description of the terms of the Separation Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Separation Agreement, a copy of which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.

    On April 3, 2026, Debra Cotter, Senior Vice President, Associate General Counsel, Corporate – Securities, Mergers and Acquisitions, was appointed Chief Legal Officer and Secretary of the Company, effective upon Ms. Cooke’s departure on April 10, 2026.

    Departure of Directors

    On April 1, 2026, each of Julie Bornstein and Fallon O’Connor separately notified the Board of their respective decisions to resign as members of the Board, effective immediately. The decision of each of Ms. Bornstein and Ms. O’Connor to resign was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Following Ms. Bornstein and Ms. O’Connor’s resignations from the Board and Ms. Comonte’s resignation as the President and Chief Executive Officer of the Company, the Board decreased the size of the Board from seven to four directors.

    Additional information about the director and management changes described above is included in the Company’s press release issued on April 3, 2026, which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

    Item 5.03.  Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

    On April 3, 2026, the Board amended Article II, Section 2.1 of the Company’s Amended and Restated Bylaws (as amended and restated, the “Bylaws”), effective immediately, to change the authorized number of directors to be no less than three and no more than 15, with the number of directors to be fixed by resolution adopted by the Board. Article II, Section 2.1 previously provided that the number of directors must be at least five and no more than 15, with the number of directors to be fixed by resolution adopted by the Board.

    The foregoing summary and description of the Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of such document, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.

    Forward-Looking Statements

    This Current Report on Form 8-K (“Form 8-K”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the anticipated appointment of Debra Cotter as Chief Legal Officer and Secretary of the Company. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “forecasts,” “guidance,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. These statements are neither promises nor guarantees, and involve known and unknown risks, uncertainties and other important factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the important factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 as well as any subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, or other filings the Company makes with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made in this Form 8-K. Forward-looking statements speak only as of the date the statements are made and are based on information available to the Company at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

     

     

    3


    Item 9.01.  Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit

      

    Description

    Exhibit 3.1    Amended and Restated Bylaws
    Exhibit 99.1    Press Release dated April 3, 2026.
    Exhibit 104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

          WW INTERNATIONAL, INC.
    DATED: April 3, 2026       By:  

    /s/ Felicia DellaFortuna

          Name:  

    Felicia DellaFortuna

          Title:  

    Chief Financial Officer

     

    4

    Get the next $WW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WW

    DatePrice TargetRatingAnalyst
    9/15/2025Market Perform
    CJS Securities
    7/26/2024$6.50 → $1.25Overweight → Equal-Weight
    Morgan Stanley
    1/3/2024$8.00Underweight
    Barclays
    12/20/2023$14.00Buy
    Guggenheim
    9/27/2023$4.00 → $10.00Sell → Hold
    Craig Hallum
    7/26/2023$5.00 → $13.00Equal-Weight → Overweight
    Morgan Stanley
    4/11/2023$3.80 → $13.00Neutral → Buy
    Goldman
    3/8/2023$4.00Hold → Sell
    Craig Hallum
    More analyst ratings

    $WW
    SEC Filings

    View All

    SEC Form 8-K filed by WW International Inc.

    8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    4/3/26 2:11:35 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by WW International Inc.

    SCHEDULE 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    3/26/26 11:05:13 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 10-K filed by WW International Inc.

    10-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    3/16/26 7:13:15 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CJS Securities initiated coverage on WW

    CJS Securities initiated coverage of WW with a rating of Market Perform

    9/15/25 10:08:29 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WW downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously

    7/26/24 7:46:12 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Barclays initiated coverage on WW with a new price target

    Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00

    1/3/24 8:36:04 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Announces Leadership Transition and Board Updates

    Office of the CEO Established to Oversee Business Operations  Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors ("the Board"). These actions follow Tara Comonte's departure from the Company, effective March 31, 2026.  The Company's Board of Directors has initiated a comprehensive search for a permanent successor with the support of a l

    4/3/26 2:09:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced that eligible Weight Watchers Med+ members will have access to subscription pricing for Wegovy® that significantly reduces out-of-pocket costs and is a result of expanded collaboration between Weight Watchers and Novo Nordisk. The new subscription offer gives Weight Watchers Med+ members access to the lowest available self-pay price in the market for doses of Wegovy not otherwise available through limited-time offers, saving cash-pay members up to $1,200 per year. The announcement coincides with Novo Nordisk's launch of the

    3/31/26 7:49:25 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

    2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026  Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh

    3/16/26 7:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney was granted 1,166 shares, increasing direct ownership by 4% to 31,442 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:12 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Bornstein Julie was granted 1,166 shares, increasing direct ownership by 67% to 2,918 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:10 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 4 filed by Director O'Connor-Brooks Fallon Julia

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:09 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney bought $643,464 worth of shares (29,057 units at $22.14) (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    11/20/25 4:01:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Kelly Denis F bought $49,897 worth of shares (64,500 units at $0.77), increasing direct ownership by 80% to 145,421 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:13:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Sistani Sima bought $48,555 worth of shares (65,000 units at $0.75), increasing direct ownership by 32% to 267,410 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:06:22 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Leadership Updates

    Live Leadership Updates

    View All

    Weight Watchers Announces Leadership Transition and Board Updates

    Office of the CEO Established to Oversee Business Operations  Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors ("the Board"). These actions follow Tara Comonte's departure from the Company, effective March 31, 2026.  The Company's Board of Directors has initiated a comprehensive search for a permanent successor with the support of a l

    4/3/26 2:09:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme

    NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking programme that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the programme, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman. "Menopause has been a new journey for me—one that's changed how I see a

    9/8/25 8:54:36 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program

    NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking program that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the program, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman "Menopause has been a new journey for me—one that's changed how I s

    9/8/25 8:50:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

    2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026  Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh

    3/16/26 7:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Schedules Third Quarter 2025 Earnings Conference Call

    NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, 2025. WeightWatchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About WeightWatchersWeightWatchers is the global leader in science-backed weight management, offering an integrated support system that co

    10/30/25 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/14/24 6:06:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/8/24 10:40:45 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by WW International Inc.

    SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)

    2/14/24 6:58:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary